Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quality of life and symptom burden among myeloproliferative neoplasm patients: do symptoms impact quality of life?

Leukemia & lymphoma - 1 Feb 2019

Langlais Blake T, Geyer Holly, Scherber Robyn, Mesa Ruben A, Dueck Amylou C

Abstract excerpt

Patients with myeloproliferative neoplasms (MPNs) are faced with high disease-related symptom burden and quality of life (QoL) decrements. This analysis assesses the extent to which individual symptoms or summary measures across symptoms impact QoL overall and within MPN subgroups. Four sets of summary measures were constructed assessing symptom prevalence and severity within group-standardized and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myeloproliferative Disorders

Share to Outcome Assessment, Health Care

Share to Phenotype

Share to Quality of Life

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 30033837
DOI: 10.1080/10428194.2018.1480768
PMCID: PMC6363896

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quality of life and symptom burden among myeloproliferative neoplasm patients: do symptoms impact quality of life?PMID 30033837Read ↗

Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group.Semantic proximity Read ↗

Instruments on symptom clusters in adult patients with hematological malignancies: A scoping reviewSemantic proximity Read ↗

Symptom Distress, Resourcefulness, and Quality of Life in Patients Receiving Chemotherapy: The Moderating Role of Cancer MetastasisSemantic proximity Read ↗

Patient-Reported Distress and Problems Among Elderly Patients with Hematological Malignancy in KoreaSemantic proximity Read ↗

Beyond Disease Control in Chronic Myeloid Leukemia: Real-World Quality of Life Across TKIs and Treatment-Free RemissionSemantic proximity Read ↗

Patient‐reported symptom burden and impact on daily activities in chronic graft‐versus‐host diseaseSemantic proximity Read ↗

Quality of Life and Symptoms of Hospitalized Hematological Cancer PatientsSemantic proximity Read ↗

Health-Related Quality of Life Following Allogeneic Hematopoietic Stem Cell TransplantationSemantic proximity Read ↗

Identification of Patient-Reported Outcome Phenotypes Among Oncology Patients With Palliative Care Needs.Semantic proximity Read ↗

Psychological phenotypes of sense of coherence: How illness perception mediates distress differently across patient subgroups with hematologic malignancies.Semantic proximity Read ↗

Symptom Clusters and Quality of Life in Ambulatory Patients With Multiple MyelomaSemantic proximity Read ↗

Quality of life in survivors of hematological malignancies stratified by cancer type, time since diagnosis and stem cell transplantationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.